P53 gene alterations in human tumors: perspectives for cancer control.
Hollstein
M
M
Deutsches Kreosforschungszentrum, Heidelberg, Germany.
Soussi
T
T
Thomas
G
G
von Brevern
M C
MC
Bartsch
D000348:Aflatoxins; D000483:Alleles; D001482:Base Composition; D002273:Carcinogens; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000235:genetics; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002886:Chromosomes, Human, Pair 17; D004252:DNA Mutational Analysis; D004251:DNA Transposable Elements; D005260:Female; D016158:Genes, p53; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000139:chemically induced / Q000235:genetics; D008175:Lung Neoplasms / Q000453:epidemiology / Q000235:genetics; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology / Q000517:prevention & control*; D009381:Neoplasms, Radiation-Induced / Q000235:genetics; D017354:Point Mutation; D017384:Sequence Deletion; D012878:Skin Neoplasms / Q000209:etiology / Q000235:genetics; D012907:Smoking / Q000009:adverse effects; D013472:Sunlight; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000096:biosynthesis
D000348:Aflatoxins; D002273:Carcinogens; D004251:DNA Transposable Elements; D016159:Tumor Suppressor Protein p53